Abstract:Objective To investigate the clinical effect of Xuebijing Injection combined with Tigefycline in the treatment of pulmonary infection of Acinetobacter Baumannii.Methods A total of 82 patients with pulmonary infection caused by Acinetobacter Baumannii treated in our hospital from January 2016 to April 2017 were selected as the subjects,and divided into control group and treatment group according to the PC random table method,with 41 cases in each group.The control group received Tegocycline,and the treatment group received Xuebijing Injection combined with Tigecycline.They were treated for 7 to 15 days.Peripheral blood was collected,and the clinical efficacy,C reactive protein (CRP),procalcitonin (PCT),immunoglobulin IgA,IgM and IgG were compared between the two groups.Results The total effective rate of the treatment group was lower than that of the control group,and the difference was statistically significant(P<0.05).After treatment,the levels of CRP,PCT,IgA in the treatment group were lower than those in the control group,the differences were statistically significant(P<0.05).The levels of IgM,IgG in the treatment group were higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusion Xuebijing injection combined with tigecycline has a remarkable effect on pulmonary infection caused by Acinetobacter Baumannii,which can reduce levels of CRP and PCT.
何巍;穆晓东;加慧. 血必净注射液联合替加环素治疗鲍曼不动杆菌肺部感染的临床效果[J]. 中国当代医药, 2019, 26(5): 31-33-37.
HE Wei;MU Xiao-dong;JIA Hui. Study on the clinical effect of Xuebijing Injection combined with Tigefycline in the treatment of pulmonary infection of Acinetobacter Baumannii. 中国当代医药, 2019, 26(5): 31-33-37.